Welcome to RLPSecurties

Stock Quotes	Board Of Directors	Income Statement	Directors Report	Change Name	Quarterly Results
High/Low	Share Holding	Balance Sheet	Auditors Report	Book Closure	Half Yearly Results
Company Profile	MF Holding	Cash Flow	Notes to Accounts	Dividend Details	Technical Chart
Locations	Investor Returns	Ratios	Banker's/Auditor's	ADR/GDR Prices	Peer Comparision

Marksans Pharma Ltd.	Ratio Analysis

NSE: MARKSANSEQ BSE: 524404ISIN: INE750C01026INDUSTRY: Pharmaceuticals

BSE

Rs 254.45

Open: 220.70

Today's Range 218.10

258.85

NSE
Rs 254.79
+34.53 (+ 13.55 %)

+34.20 (+ 13.44 %)

Prev Close: 220.25

52 Week Range 156.00

270.60

You can view the Ratio Analysis for the last 5 years.

Market Cap. (Rs.)	11546.16 Cr.	P/BV	4.12	Book Value (Rs.)	61.83
52 Week High/Low (Rs.)	271/155	FV/ML	1/1	P/E(X)	30.34
Bookclosure	01/08/2025	EPS (Rs.)	8.40	Div Yield (%)	0.31

Particulars	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22
Months	12	12	12	12	12
Source Of Info (AR = Annual Report, PR = Press Release)	PR	AR	AR	AR	AR
FaceValue	1.00	1.00	1.00	1.00	1.00

PER SHARE RATIOS

Basic EPS (Rs.)	9.22	8.40	6.92	6.41	4.51
Diluted EPS (Rs.)	9.22	8.40	6.92	6.41	4.51
Cash EPS (Rs.)	11.45	10.28	8.59	7.00	5.66
Book Value[Excl.RevalReserv]/Share (Rs.)	66.71	54.44	46.03	38.95	29.88
Book Value[Incl.RevalReserv]/Share (Rs.)	66.71	54.44	46.03	38.95	29.88
Revenue From Operations / Share (Rs.)	65.12	57.88	48.05	40.87	36.42
PBDIT / Share (Rs.)	15.08	13.22	11.23	8.80	7.35
PBIT / Share (Rs.)	12.90	11.38	9.59	7.65	6.25
PBT / Share (Rs.)	12.37	11.12	9.35	7.45	6.05
Net Profit / Share (Rs.)	9.27	8.44	6.95	5.85	4.56
NP After MI And SOA / Share (Rs.)	9.22	8.40	6.92	5.88	4.56

PROFITABILITY RATIOS

PBDIT Margin (%)	23.15	22.83	23.37	21.52	20.17
PBIT Margin (%)	19.81	19.65	19.96	18.72	17.16
PBT Margin (%)	18.99	19.21	19.45	18.23	16.60
Net Profit Margin (%)	14.23	14.58	14.46	14.32	12.53
NP After MI And SOA Margin (%)	14.16	14.51	14.40	14.37	12.53
Return on Networth / Equity (%)	13.82	15.42	15.19	15.25	15.53
Return on Capital Employeed (%)	17.53	18.66	18.97	18.75	19.93
Return On Assets (%)	10.82	11.74	11.70	12.15	11.39
Total Debt / Equity (X)	0.01	0.01	0.01	0.02	0.03
Asset Turnover Ratio (%)	0.83	0.88	0.89	0.96	1.04

LIQUIDITY RATIOS

Current Ratio (X)	5.17	4.62	4.78	4.91	3.37
Quick Ratio (X)	3.32	2.85	3.19	3.49	2.18
Inventory Turnover Ratio (X)	3.25	3.58	1.21	1.35	1.30
Dividend Payout Ratio (NP) (%)	0.00	7.14	7.22	3.81	5.47
Dividend Payout Ratio (CP) (%)	0.00	5.86	5.84	3.19	4.41
Earning Retention Ratio (%)	0.00	92.86	92.78	96.19	94.53
Cash Earning Retention Ratio (%)	0.00	94.14	94.16	96.81	95.59

COVERAGE RATIOS

Interest Coverage Ratio (%)	28.32	51.37	45.43	43.67	35.61
Interest Coverage Ratio (Post Tax) (%)	18.41	33.81	29.11	30.07	23.12

VALUATION RATIOS

Enterprise Value (Cr.)	6190.87	9417.36	6244.01	2540.86	1577.14
EV / Net Operating Revenue (X)	2.10	3.59	2.87	1.37	1.06
EV / EBITDA (X)	9.06	15.72	12.27	6.37	5.24
MarketCap / Net Operating Revenue (X)	2.41	3.84	3.15	1.72	1.25
Retention Ratios (%)	0.00	92.85	92.77	96.18	94.52
Price / BV (X)	2.36	4.08	3.33	1.83	1.55
Price / Net Operating Revenue (X)	2.41	3.84	3.15	1.72	1.25
EarningsYield	0.05	0.03	0.04	0.08	0.10

Market

Derivatives

Mutual Fund

IPO

Quick Links

Marksans Pharma Ltd.

Ratio Analysis